Senesco Technologies, Inc. reports EPS of -$0.48

Senesco Technologies, Inc. (SNTI): FQ2 EPS of -$0.48

From other sites
Comments (2)
  • russleehowe
    , contributor
    Comments (80) | Send Message
    One of the greatest stock opportunities out there. Major, major speculation of course. They are doing research for and have a product in the pipeline for multiple myeloma, which I have. I just hope I live long enough to see their product reach the market. Myeloma is the blood cancer Tom Brokaw just announced he had. One of the worst along with brain and pancreatic cancer.
    18 Feb 2014, 09:09 PM Reply Like
  • joanmerkt
    , contributor
    Comment (1) | Send Message
    I hope you live long enough also. The genious idea Senesco has really should work. I, like you, wish the testing didn't take so long. There should be some way some unnecessary steps could be elimintated from the process of getting something so important to so many people who need it.
    4 May 2014, 05:40 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs